Metformin enhanced the sensitivity of osteosarcoma stem cells to cisplatin by decreasing the expression level of PKM2 and inhibited glucose uptake, lactate production, and ATP production in osteosarcoma stem cells [212]. This evidence concerns the gene PKM and osteosarcoma.